Article Information
- Received January 9, 2009
- Accepted February 27, 2009
- First published April 1, 2009.
- Version of record published April 1, 2009.
Author Information
- Yoshiho Ikeuchi1,*,
- Judith Stegmüller1,*,
- Stuart Netherton2,
- Mai Anh Huynh1,
- Masayuki Masu3,
- David Frank4,
- Shirin Bonni2, and
- Azad Bonni1
- 1Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115,
- 2Southern Alberta Cancer Research Institute and Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada T2N 4N1,
- 3Department of Molecular Neurobiology, Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan, and
- 4Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115
- Correspondence should be addressed to Azad Bonni at the above address. azad_bonni{at}hms.harvard.edu
Author contributions
-
↵*Y.I. and J.S. contributed equally to this work.
Disclosures
- Received January 9, 2009.
- Accepted February 27, 2009.
-
This work was supported by National Institutes of Health (NIH) Grant NS051255 (A.B.), the Harvard Medical School–Merck-Sponsored Research Program (A.B.), the Alberta Cancer Research Institute (ACRI; S.B.), the Uehara Memorial Foundation (Y.I.), the Naito Foundation (Y.I.), the Human Frontier Science Program (Y.I.), a Charles A. King Trust (Bank of America, Cotrustee) Postdoctoral Fellowship (J.S.), and NIH Training Grant GM077226 (M.A.H.). S.B. is an Alberta Heritage Foundation for Medical Research (AHFMR) Scholar. S.N. is an AHFMR and ACRI Postdoctoral Fellow. We thank Samantha Keough for technical assistance, Genevieve Konopka for helpful discussions, Sheng-Cai Lin for providing the pSuper/ccd1i plasmid, and Zhen-Ge Luo for providing the Dvl–myc expression plasmid.
- Correspondence should be addressed to Azad Bonni at the above address. azad_bonni{at}hms.harvard.edu
